RecruitingNCT04106830
Clinical and Imaging Cohort of Neuroinflammation Diseases in China (CLUE)
Studying Neuromyelitis optica spectrum disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Beijing Tiantan Hospital
- Principal Investigator
- Yaou Liu, PhDBeijing Tiantan Hospital
- Intervention
- Intravenous steroid(drug)
- Enrollment
- 1000 enrolled
- Eligibility
- 16-75 years · All sexes
- Timeline
- 2019 – 2028
Study locations (1)
- Beijing Tiantan Hospital, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04106830 on ClinicalTrials.govOther trials for Neuromyelitis optica spectrum disorder
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07377305Efficacy and Safety of Transcranial Temporal Interference Stimulation (tTIS) for Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder (NMOSD)Tang-Du Hospital
- RECRUITINGNCT05891379Inebilizumab in Acute Neuromyelitis Optica Spectrum DisordersXuanwu Hospital, Beijing
- RECRUITINGNCT05004493Biorepository and Registry for Plasma Exchange PatientsCharles M Knudson
- ACTIVE NOT RECRUITINGNCT01623076The Longitudinal CONQUER Study of Rare Neuroimmunologic DisordersUniversity of Texas Southwestern Medical Center